Skip to main content
NVDA-2.25%AAPL+1.57%GOOGL-0.06%MSFT+0.03%AMZN+0.06%TSM-1.07%SPCX+2.86%AVGO-0.14%META-0.24%TSLA-0.42%SKHY-3.56%MU-4.74%BRK-B-0.27%LLY+0.22%JPM-0.67%AMD-3.20%WMT+0.17%V-0.02%XOM+0.42%ASMLa-1.66%JNJ-0.47%INTC-4.99%MA-0.34%0700.HK-1.94%ORCL-2.93%1398.HK+0.79%BAC-0.62%ABBV+0.39%CSCO-0.88%CVX-0.17%COST+0.13%LRCX-4.58%KO+1.03%CAT-1.61%AMAT-2.27%0005.HK-0.78%AP2d-1.55%UNH-0.51%DELL-3.43%HSBA.L-1.30%MS-0.69%PG-0.16%GE-0.24%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.12%HD-1.18%GS-0.90%0939.HK+1.66%NZDJPY-2.59%AUDJPY-1.84%CHFJPY-1.57%NZDCAD-1.46%EURNZD+1.42%GBPNZD+1.37%USDJPY-1.32%NZDUSD-1.31%GBPJPY-1.24%EURJPY-1.21%CADJPY-1.14%NZDCHF-1.06%USDZAR+0.91%EURZAR+0.84%AUDNZD+0.78%GBPZAR+0.76%USDNOK+0.76%USDSEK+0.75%AUDCAD-0.73%EURNOK+0.69%EURSEK+0.68%AUDDKK-0.67%EURAUD+0.64%GBPAUD+0.59%CHFNOK+0.55%CHFSEK+0.54%AUDUSD-0.53%AUDSGD-0.52%USDTHB+0.48%USDMXN+0.44%GBPTRY+0.41%CADCHF+0.41%NZDSGD-0.37%EURCHF+0.35%NOKJPY-0.33%GBPHKD+0.32%GBPCHF+0.32%USDPLN+0.31%GBPMXN-0.28%AUDCHF-0.28%USDCHF+0.26%EURPLN+0.24%SGDJPY+0.21%USDSGD+0.21%USDILS+0.16%NZDMXN-0.16%USDCAD-0.16%EURSGD+0.14%GBPCAD-0.11%PLNJPY+0.11%USDTRY+0.11%EURUSD+0.09%EURCZK-0.08%EURHKD-0.08%USDCNH+0.08%GBPUSD+0.08%EURCAD-0.07%USDDKK+0.07%GBPSGD+0.05%EURGBP+0.04%USDCOP-0.04%EURCNH+0.03%AUDNOK+0.02%USDHKD+0.01%EURDKK0.00%CHFSGD0.00%XPTUSD-5.44%UKOIL+4.82%XAGUSD-4.74%HG1-4.74%GAGUSD-4.72%USOIL+4.60%SUGAR+2.62%GAUUSD-1.00%XAUUSD-0.99%COTTON+0.71%COFFEE-0.61%XNGUSD+0.61%BTCUSD-1.69%ETHUSD-1.16%USDTUSD-0.03%XRPUSD-3.13%SOLUSD-2.14%TRXUSDT-0.03%ZECUSDT-7.21%DOGEUSD-3.27%XMRUSDT-1.52%LINKUSD-1.88%XLMUSD-2.42%BCHUSDT-10.66%LTCUSD-2.36%UNIUSD-3.05%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.11%TAOUSDT-5.96%AAVEUSD-3.34%DOTUSDT-3.52%ICPUSDT-1.44%ONDOUSDT-3.87%WLDUSDT-3.39%ARBUSDT-0.46%ATOMUSDT-5.13%JUPUSDT-4.25%INJUSDT-5.65%STXUSDT-4.53%FETUSDT-4.15%TIAUSDT-2.18%PYTHUSDT-1.47%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-2.91%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-6.03%IOTAUSDT-4.48%AXSUSDT-2.90%FARTCOINUSDT-4.41%EOSUSDT-1.67%DYDXUSDT-3.58%ORDIUSDT-1.88%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.25%AAPL+1.57%GOOGL-0.06%MSFT+0.03%AMZN+0.06%TSM-1.07%SPCX+2.86%AVGO-0.14%META-0.24%TSLA-0.42%SKHY-3.56%MU-4.74%BRK-B-0.27%LLY+0.22%JPM-0.67%AMD-3.20%WMT+0.17%V-0.02%XOM+0.42%ASMLa-1.66%JNJ-0.47%INTC-4.99%MA-0.34%0700.HK-1.94%ORCL-2.93%1398.HK+0.79%BAC-0.62%ABBV+0.39%CSCO-0.88%CVX-0.17%COST+0.13%LRCX-4.58%KO+1.03%CAT-1.61%AMAT-2.27%0005.HK-0.78%AP2d-1.55%UNH-0.51%DELL-3.43%HSBA.L-1.30%MS-0.69%PG-0.16%GE-0.24%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.12%HD-1.18%GS-0.90%0939.HK+1.66%NZDJPY-2.59%AUDJPY-1.84%CHFJPY-1.57%NZDCAD-1.46%EURNZD+1.42%GBPNZD+1.37%USDJPY-1.32%NZDUSD-1.31%GBPJPY-1.24%EURJPY-1.21%CADJPY-1.14%NZDCHF-1.06%USDZAR+0.91%EURZAR+0.84%AUDNZD+0.78%GBPZAR+0.76%USDNOK+0.76%USDSEK+0.75%AUDCAD-0.73%EURNOK+0.69%EURSEK+0.68%AUDDKK-0.67%EURAUD+0.64%GBPAUD+0.59%CHFNOK+0.55%CHFSEK+0.54%AUDUSD-0.53%AUDSGD-0.52%USDTHB+0.48%USDMXN+0.44%GBPTRY+0.41%CADCHF+0.41%NZDSGD-0.37%EURCHF+0.35%NOKJPY-0.33%GBPHKD+0.32%GBPCHF+0.32%USDPLN+0.31%GBPMXN-0.28%AUDCHF-0.28%USDCHF+0.26%EURPLN+0.24%SGDJPY+0.21%USDSGD+0.21%USDILS+0.16%NZDMXN-0.16%USDCAD-0.16%EURSGD+0.14%GBPCAD-0.11%PLNJPY+0.11%USDTRY+0.11%EURUSD+0.09%EURCZK-0.08%EURHKD-0.08%USDCNH+0.08%GBPUSD+0.08%EURCAD-0.07%USDDKK+0.07%GBPSGD+0.05%EURGBP+0.04%USDCOP-0.04%EURCNH+0.03%AUDNOK+0.02%USDHKD+0.01%EURDKK0.00%CHFSGD0.00%XPTUSD-5.44%UKOIL+4.82%XAGUSD-4.74%HG1-4.74%GAGUSD-4.72%USOIL+4.60%SUGAR+2.62%GAUUSD-1.00%XAUUSD-0.99%COTTON+0.71%COFFEE-0.61%XNGUSD+0.61%BTCUSD-1.69%ETHUSD-1.16%USDTUSD-0.03%XRPUSD-3.13%SOLUSD-2.14%TRXUSDT-0.03%ZECUSDT-7.21%DOGEUSD-3.27%XMRUSDT-1.52%LINKUSD-1.88%XLMUSD-2.42%BCHUSDT-10.66%LTCUSD-2.36%UNIUSD-3.05%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.11%TAOUSDT-5.96%AAVEUSD-3.34%DOTUSDT-3.52%ICPUSDT-1.44%ONDOUSDT-3.87%WLDUSDT-3.39%ARBUSDT-0.46%ATOMUSDT-5.13%JUPUSDT-4.25%INJUSDT-5.65%STXUSDT-4.53%FETUSDT-4.15%TIAUSDT-2.18%PYTHUSDT-1.47%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-2.91%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-6.03%IOTAUSDT-4.48%AXSUSDT-2.90%FARTCOINUSDT-4.41%EOSUSDT-1.67%DYDXUSDT-3.58%ORDIUSDT-1.88%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%
AT

Akebia Therapeutics, Inc. (AKBA)

NASDAQ • Healthcare

$0.95
-$0.07 (-7.4%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$1.03
Previous Close$0.95
Day Range$0.95 - $1.05
Avg. Volume (3M)8.4M
Market Cap$255.8M
52 Week Range
$0.81$3.2
Next EarningsIn 60 daysNov 9, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$49.1M100%
Gross Profitminus cost of goods$38.7M79%

In plain terms: out of every $100 in revenue, Akebia Therapeutics, Inc. currently loses $18.

Fundamentals & Financials

Revenue (TTM)
$219M
Net Income (TTM)
-$29.6M
EPS (TTM)
-$0.11
ROA (TTM)
-8.48%
Current Ratio
1.43

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-66.7%Q1 2026-$0.05
-200.0%Q2 2026-$0.03
+52.4%Q3 2026-$0.02
Next

Nov 9

in 60 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc. is a biotechnology company focused on discovering and commercializing therapies for kidney diseases. Listed on the NASDAQ Global Market under AKBA, it sells and develops treatments for chronic kidney disease complications and generated $236.2 million of revenue in FY2025.

Name
Akebia Therapeutics, Inc.
CEO
John Butler
Website
www.akebia.com
Industry
Healthcare
Year Founded
2007
Employees
194

Today's Snapshot

AI-generated

AKBA opened 0.9% below yesterday's close, in line with a flat sector.

Trading Volume

Below 10d avg (8.9M)

1.1M

vs S&P 500 Today

Outperforming Market

+0.58%

Updated: September 10, 2026 at 14:56 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
AKBA presents a sell bias marked by weak trend structure and price positioned below major longer-term averages. ADX near 19 implies little directional conviction, while short-term momentum is tepid with RSI and MACD near neutral and stochastic failing to show clear strength. The stock sits under most medium and long moving averages, including the 200-day level, and the pivot around $0.98 is above today’s price of about $0.95. Volatility is elevated with an ATR near $0.06 (about 6.8%). Technical takeaway: elevated volatility and price below key averages support a sell bias in a low-trend environment.
All signals
  • EMA (5 indicators)$0.96 - $1.43
    Sell
  • RSI (14)45.61
    Neutral
  • Stochastic %K (14, 3, 3)65.95
    Neutral
  • MACD Level (12, 26)-0.03
    Neutral

Peers & Related Assets

CRVSCorvus Pharmaceuticals, Inc.
$13.33-4.3%
OLMAOlema Pharmaceuticals, Inc.
$10.36-5.7%
RIGLRigel Pharmaceuticals, Inc.
$47.22-0.3%
FDMT4D Molecular Therapeutics, Inc.
$14.18-3.1%
ZVRAZevra Therapeutics, Inc.
$12.04-5.0%
PRTAProthena Corporation plc
$9.3-2.5%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.